Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Forte Biosciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +4 vs. Q4 2024
- Shares held
- 5.17M
- +895.5K (+20.9%) vs. Q4 2024
- Total value
- $40.4M
- −$56.7M (−58.4%) vs. Q4 2024
- New holders
- 6
- 8 more added
- Sold out
- 2
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 3 | $23 | 0.00% | −2,100−99.9% | Reduced |
| REAP Financial Group, LLC | 3 | $23 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 8 | $62 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 12 | $93 | 0.00% | 00.0% | Unchanged |
| Private Trust Co NA | 42 | $326 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $357 | 0.00% | +36+360.0% | Added |
| Group One Trading, L.P. | 104 | $807 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 151 | $1.17K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 155 | $1.20K | 0.00% | +99+176.8% | Added |
| UBS Group AG | 527 | $4.09K | 0.00% | +527 | New |
| Tower Research Capital LLC (TRC) | 1,792 | $13.9K | 0.00% | +1,692+1,692.0% | Added |
| Royal Bank of Canada | 3,342 | $26.0K | 0.00% | −442−11.7% | Reduced |
| Garde Capital, Inc. | 3,960 | $30.7K | 0.00% | +3,960 | New |
| Quest Partners LLC | 4,217 | $32.7K | 0.00% | +4,217 | New |
| BlackRock, Inc. | 6,803 | $52.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 14,605 | $113.3K | 0.00% | +14,605 | New |
| Acuta Capital Partners, LLC | 18,469 | $143.3K | 0.17% | +330+1.8% | Added |
| Geode Capital Management, LLC | 60,082 | $466.3K | 0.00% | +43,205+256.0% | Added |
| Farallon Capital Management, L.L.C. | 70,429 | $546.5K | 0.00% | +35,429+101.2% | Added |
| Vanguard Group Inc | 88,951 | $690.3K | 0.00% | +62,557+237.0% | Added |
| Boothbay Fund Management, LLC | 89,191 | $692.1K | 0.02% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 136,821 | $1.06M | 0.15% | +136,821 | New |
| Woodline Partners LP | 204,822 | $1.59M | 0.01% | +547+0.3% | Added |
| Cable Car Capital LLC | 219,604 | $1.70M | 1.93% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 593,088 | $4.60M | 0.11% | −6,912−1.2% | Reduced |
| BVF Inc | 594,282 | $4.61M | 0.19% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 609,225 | $4.73M | 1.54% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 619,981 | $4.81M | 20.42% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 910,609 | $7.07M | 0.04% | −223,335−19.7% | Reduced |
| Janus Henderson Group PLC | 920,000 | $7.39M | 0.00% | +920,000 | New |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −95,742−100.0% | Sold out |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0 | $0 | 0.00% | −7−100.0% | Sold out |